Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

NCT: NCT03298477 · COMPLETED

NCT IDNCT03298477
StatusCOMPLETED
Start Date2017-12-01
Completion2025-08-16

Brief Summary

Prospective, multicenter, single arm study with consecutive, eligible subject enrollment at each site. All subjects will undergo the Endovascular Aneurysm repair procedure with the Nellix System.

Frequently Asked Questions

What is EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study?

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study is a clinical trial registered under NCT03298477. Current status: COMPLETED.

What is the status of NCT03298477?

The current status of NCT03298477 (EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study) is: COMPLETED.

When did EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study start?

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study started on 2017-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑